| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2011 | US20110060058 Inhibition of the Survival of Ovarian Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060057 Inhibition of the Survival of Skin Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060056 Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060055 Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060054 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof |
| 03/10/2011 | US20110060053 Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol |
| 03/10/2011 | US20110060051 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
| 03/10/2011 | US20110060050 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas |
| 03/10/2011 | US20110060049 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 03/10/2011 | US20110060048 Removing alcohol in vivo through esterification |
| 03/10/2011 | US20110060047 Approaches to treat cancer using hb-egf inhibitors |
| 03/10/2011 | US20110060046 Agent and food for preventing/improving functional digestive disorder |
| 03/10/2011 | US20110060045 Anti-diabetic cataract compounds and their uses |
| 03/10/2011 | US20110060044 Aliphatic acid-containing n-halogenated amino acid formulations |
| 03/10/2011 | US20110060043 Inhibitors of cell proliferation and uses thereof |
| 03/10/2011 | US20110060042 External preparation for skin |
| 03/10/2011 | US20110060041 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 03/10/2011 | US20110060040 Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
| 03/10/2011 | US20110060038 Nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof |
| 03/10/2011 | US20110060037 Use of npy y5 receptor antagonists for the prevention of psycho-stimulant and opioid abuse |
| 03/10/2011 | US20110060036 Branched Multifunctional Nanoparticle Conjugates And Their Use |
| 03/10/2011 | US20110060035 Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| 03/10/2011 | US20110060033 Fertility restorer gene and fertility restoration method for cw-type male sterile cytoplasm of rice |
| 03/10/2011 | US20110060032 Lipid encapsulating interfering rna |
| 03/10/2011 | US20110060031 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus |
| 03/10/2011 | US20110060030 Modulation of apolipoprotein c-iii expression |
| 03/10/2011 | US20110060029 Method of treating cancer by modulating epac |
| 03/10/2011 | US20110060028 Combination therapy |
| 03/10/2011 | US20110060026 Indoles Active on CRTH2 Receptor |
| 03/10/2011 | US20110060025 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060023 Parasiticidal formulation |
| 03/10/2011 | US20110060022 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic Acid - 465 |
| 03/10/2011 | US20110060021 Histone deacetylase inhibitors and uses thereof |
| 03/10/2011 | US20110060020 Process for release of biologically active species |
| 03/10/2011 | US20110060019 Heteroaryl-ureas and their use as glucokinase activators |
| 03/10/2011 | US20110060017 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 03/10/2011 | US20110060016 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 03/10/2011 | US20110060015 5-[5-[2-(3,5-BIS(Trifluoromethyl)Phenyl)-2-MethylpropanoMethylpropanoylmethylamino]-4-(4-Fluoro-2-Methylphenyl)]-2-Pyridinyl-2-Alkyl-Prolinamide As NK1 Receptor Antagonists |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060013 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060011 Oxazole compounds compositions and methods of use |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060008 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110060005 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110060003 Lonidamine analogues for fertility management |
| 03/10/2011 | US20110060002 Conglomerates of tenatoprazole potassium salts |
| 03/10/2011 | US20110060001 Thienopyridone derivatives as amp- activated protein kinase (ampk) activators |
| 03/10/2011 | US20110060000 Acridine analogs in the treatment of gliomas |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059998 Kit, composition, product or medicament for treating cognitive impairment |
| 03/10/2011 | US20110059997 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF |
| 03/10/2011 | US20110059996 Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059994 Composition for preventing or treating brain cancers |
| 03/10/2011 | US20110059993 1-(1-(2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino)-1H-Pyrazolo[4,3-D]Pyrimidin-5-YL) Piperidine-4-Carboxylic Acid And Salts Thereof |
| 03/10/2011 | US20110059992 New Compounds |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059988 Isoxazoline compositions and their use as antiparasitics |
| 03/10/2011 | US20110059987 Co-Crystals and Pharmaceutical Compositions Comprising the Same |
| 03/10/2011 | US20110059986 Intermittent dosing regimen for overweight and obese subjects |
| 03/10/2011 | US20110059985 Novel formulation |
| 03/10/2011 | US20110059984 Heterocycles useful as modulators of ion channels |
| 03/10/2011 | US20110059983 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain |
| 03/10/2011 | US20110059982 Azaindole compounds for treatment of central nervous system disorders |
| 03/10/2011 | US20110059981 New Pyridine Analogues V |
| 03/10/2011 | US20110059980 Solid preparation for oral administration |
| 03/10/2011 | US20110059979 Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators |
| 03/10/2011 | US20110059978 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 03/10/2011 | US20110059977 USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended |
| 03/10/2011 | US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 03/10/2011 | US20110059975 Non-nucleoside reverse transcriptase inhibitors |
| 03/10/2011 | US20110059974 Novel retinamide retinoic acid metabolism blocking agents |
| 03/10/2011 | US20110059973 Pyrazole Compounds for Controlling Invertebrate Pests |
| 03/10/2011 | US20110059972 1,4-naphthoquinones derivatives and therapeutic use thereof |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059967 Therapeutic compounds |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/10/2011 | US20110059961 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/10/2011 | US20110059960 Method of treating inherited severe neutropenia |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059958 Morpholinone compounds as factor ixa inhibitors |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059956 Therapeutic agent for pain |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059954 Cgrp antagonists |
| 03/10/2011 | US20110059953 Compounds for use in stabilizing p53 mutants |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |